Butyrate and Propionate are Negatively Correlated with Obesity and Glucose Levels in Patients with Type 2 Diabetes and Obesity
Shi Zhang,Yanju Zhang,Jing Li,Xincheng Wang,Minying Zhang,Meiyang Du,Weiran Jiang,Chunjun Li
DOI: https://doi.org/10.2147/dmso.s434499
2024-04-03
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Shi Zhang, 1 Yanju Zhang, 2 Jing Li, 1 Xincheng Wang, 1 Minying Zhang, 3 Meiyang Du, 1 Weiran Jiang, 4 Chunjun Li 1 1 Department of Endocrinology, Health Management Center, Tianjin Union Medical Center, Nankai University Affiliated Hospital, Tianjin, People's Republic of China; 2 Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China; 3 School of Medicine, Nankai University, Tianjin, People's Republic of China; 4 Eastman Institute for Oral Health, University of Rochester Medical Center, Rochester, NY, USA Correspondence: Chunjun Li, Department of Endocrinology, Health Management Center, Tianjin Union Medical Center, Nankai University Affiliated Hospital, Tianjin, People's Republic of China, Email Background: Growing evidence has demonstrated the important roles of gut microbiota and short chain fatty acids, especially acetate, propionate and butyrate, in the development of obesity and metabolic diseases. To date, the effects of acetate, propionate and butyrate on human adiposity and glucose metabolism remain controversial. This study aimed to explore the associations of systemically acetate, propionate and butyrate with obesity and glucose homeostasis in patients with type 2 diabetes (T2D) and obesity. Methods: A total of 12 patients with T2D and obesity and 8 age- and sex-matched healthy individuals with BMI < 24 kg/m 2 were enrolled in this study. Height, weight, body composition, blood pressure, biochemical indices, a 75-g oral glucose tolerance test, and plasma acetate, propionate and butyrate were measured at baseline. Then, participants in T2D group were given a weight control therapy, in addition to conventional medication, and all the measurements were repeated 12 months from baseline. The direct segmental multi-frequency bioelectrical impedance analysis was used to assess body composition. Acetate, propionate and butyrate levels were determined by liquid chromatography coupled to tandem mass spectrometry. Results: Butyrate concentration significantly increased from baseline after obvious weight loss ( P < 0.05). Correlation analysis showed that propionate was negatively correlated with percent of body fat (PBF) and 2-h plasma glucose (2-h PG) ( P < 0.05), and butyrate was negatively associated with body mass index, visceral fat area, PBF and 2-h PG ( P < 0.05). No association was found between acetate and obesity. Conclusion: Butyrate and propionate are negatively correlated with obesity and glucose levels in patients with T2D and obesity. Keywords: obesity, type 2 diabetes, gut microbiota, short chain fatty acids The prevalence of obesity and its related metabolic disorders has been ascending dramatically in the past few decades worldwide. 1 Obesity is the result of a long-term imbalance between energy intake and energy expenditure, characterized by excessive deposition of adipose tissue leading to increased release of free fatty acids into the circulation, chronic low-grade inflammation of the body and eventually the development of metabolic diseases such as type 2 diabetes (T2D). 2 Obesity and T2D pandemic have become a major public health problem globally. The pathogenesis and treatment of obesity have been the focus of researches in the past few years. Recently, the relationship between obesity and its related metabolic disturbances and gut microbiota and short chain fatty acids (SCFAs) derived from the gut has been gradually recognized. 3,4 SCFAs are the end products of intestinal microbial fermentation of undigested foods, and the distal ileum and proximal colon are generally the major production sites of SCFAs. After formation in the gut, SCFAs are absorbed through the colon and transferred into the systemic circulation. There are seven types of SCFAs in peripheral circulation, among which acetate, propionate and butyrate account for the most majority. 5 Acetate, propionate and butyrate have been shown to play important roles in host energy metabolism and glucose homeostasis. 6 The results of a meta-analysis suggested that acetate administration (apple cider vinegar consumption) had a favorable effect on glycemic parameters and lipid profiles. 7 A study conducted by Yoshida et al showed that propionate might have the potential preventive and therapeutic effects on diabetes by suppressing gluconeogenesis. 8 Wu et al found that the abundance of butyrate-producing bacteria significantly decreased in patients with obesity and T2D, and this result was independent of metformin treatment. 9 Growing evidence has demonstrated -Abstract Truncated-
endocrinology & metabolism